Ravelcare Ltd. IPO is a Book Build Issue consisting solely of fresh issue of upto 0.19 crore equity shares.
The equity shares are proposed to be listed on the BSE SME. Marwadi Chandarana Intermediaries Brokers Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Ravelcare IPO DRHP for more details.
IPO Date | [.] |
Listing Date | [.] |
Face Value | ₹10 per share |
Issue Price Band | [.] to [.] per share |
Lot Size | |
Sale Type | Fresh Capital |
Total Issue Size | 19,00,000 shares (aggregating up to ₹[.] Cr) |
Issue Type | Bookbuilding IPO |
Listing At | BSE SME |
Share Holding Pre Issue | 50,05,000 shares |
Share Holding Post Issue | 69,05,000 shares |
Investor Category | Shares Offered |
---|---|
QIB Shares Offered | Not more than 50% of the Net Issue |
Retail Shares Offered | Not less than 35% of the Net Issue |
NII Shares Offered | Not less than 15% of the Net Issue |
Description | Date |
---|---|
Filed with SEBI/Exchange | Thu, Aug 1, 2024 |
Offer document returned | Tue, May 13, 2025 |
Filed with SEBI/Exchange | Wed, Jul 30, 2025 |
SEBI/Exchange approval received | Fri, Sep 12, 2025 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a comprehensive range of haircare, skincare, bodycare, and scalp care products tailored to individual needs.
The company operates primarily through its website and online marketplaces such as Amazon, Flipkart, and Myntra, along with quick commerce platforms like Blinkit. In FY 2024–25, Ravelcare expanded its presence internationally, catering to customers in the UAE, Australia, Canada, Germany, the USA, and Saudi Arabia.
To ensure supply chain reliability and timely product delivery, the company manages logistics and warehousing operations across central Indian states. Additionally, Ravelcare plans to set up its integrated manufacturing facility in Mauje-Peth, Amravati, Maharashtra, with a proposed installed capacity of 1,050 TPA. This facility will house R&D, manufacturing, packaging, warehousing, and distribution under one roof.
Product Offerings
Ravelcare’s portfolio spans four key segments:
Haircare: Includes shampoos, conditioners, masks, oils, and styling products tailored to concerns like hair fall, frizz, and damage from chemical treatments. Products are customized via digital consultations and are sold through online platforms.
Skincare comprises cleansers, serums, moisturisers, sunscreens, and treatments for acne, dryness, pigmentation, and sensitivity. Customisation is based on digital skin assessments.
Bodycare: Offers body washes and lotions designed for hydration, cleansing, and skin barrier repair, addressing conditions like dryness and sensitivity.
Scalp Care: Features targeted treatments such as anti-dandruff tonics, hair growth serums, and approved hair fall control ampoules for issues like dryness, flaking, and buildup.
As of June 30, 2025, the company employed 25 professionals across departments.
Competitive Strengths
Wide and Diversified Customer Base: The company serves a broad domestic and international customer base through a distributed warehousing model and third-party logistics, ensuring fast and reliable delivery.
Digital-First Distribution: Operating primarily through D2C channels, Ravelcare reduces dependency on intermediaries and controls the entire customer journey—from discovery to delivery—allowing competitive pricing and consistent service.
Customer-Centric Approach: Ravelcare builds strong relationships via a personalised digital consultation process, enabling the brand to understand individual needs and provide tailored product recommendations. Word-of-mouth from satisfied customers drives organic growth.
Innovation-Led Product Development: The company continuously innovates based on customer feedback and digital interactions. Product development includes concept ideation, formulation, regulatory compliance, testing, and market positioning, driven by structured consumer insights.
With its focus on personalisation, international expansion, and digital innovation, Ravelcare Ltd. positions itself as a modern, data-driven beauty and personal care brand addressing the evolving needs of customers globally.
Ravelcare Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 4% between the financial year ending with March 31, 2025 and March 31, 2024.
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
Assets | 12.95 | 9.47 | 1.74 |
Total Income | 25.30 | 22.28 | 3,49,370.00 |
Profit After Tax | 5.25 | 5.02 | 0.42 |
EBITDA | 6.82 | 6.65 | 0.51 |
Net Worth | 10.34 | 5.10 | 0.07 |
Reserves and Surplus | 5.34 | 5.09 | 0.07 |
Total Borrowing | 0.04 | 0.41 | |
Amount in ₹ Crore |
KPI | Values |
---|---|
ROE | 67.97% |
ROCE | 68.30% |
RoNW | 50.73% |
PAT Margin | 21.01% |
EBITDA Margin | 27.30% |
Pre IPO | Post IPO | |
---|---|---|
EPS Rs | 10.18 | 7.27 |
The Company Ravelcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
---|---|---|
1 | Marketing and advertisement expenses toward enhancing the awareness and visibility of the brand | 11.50 |
2 | Setting up a new manufacturing facility located at Mauje-Peth in Amravati (“Proposed facility”) | 8.08 |
3 | General Corporate Purposes |
Ravelcare Ltd.
Off-126, Neo Corporate Plaza
Cabin B, Ramchandra Lane Extension
Malad, Mumbai
Malad, Maharashtra, 400064
Phone: +91 87792 06822
Email: pragya@ravelcare.com
Website: http://www.ravelcare.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: ravelcare.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Ravelcare IPO is a SME IPO of 19,00,000 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at . The minimum order quantity is .
The Ravelcare IPO open and close dates are not available as of now.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Ravelcare IPO using UPI as a payment gateway. Zerodha customers can apply in Ravelcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Ravelcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Ravelcare IPO dates are not announced. Please check back again after some time.
Ravelcare IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Ravelcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Ravelcare IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Ravelcare IPO allotment status.
The Ravelcare IPO listing date is not yet announced. The tentative date of Ravelcare IPO listing is [.].
Useful Articles